F
Fresenius Medical Care AG (FMS)
NYQ – Real Time Price. Currency in USD
22.24
+0.48 (2.21%)
At close: May 12, 2026, 4:00 PM EDT
22.68
+0.44 (1.98%)
After-hours: May 12, 2026, 6:48 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
22.24
+0.48 (2.21%)
At close: May 12, 2026, 4:00 PM EDT
22.68
+0.44 (1.98%)
After-hours: May 12, 2026, 6:48 PM EDT
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
| Name | Position |
|---|---|
| Dr. Charles Hugh-Jones M.D. | Global Chief Medical Officer & Member of Management Board |
| Dr. Dominik Heger | Executive VP and Head of Investor Relations, Strategic Development & Communications |
| Dr. Gail-Suzanne Brown | Senior Vice President of Research & Development |
| Dr. Jorg Haring | Member of the Management Board, Global Head of Legal,Compliance & Human Resources and Labor Director |
| Mr. Craig Cordola FACHE, M.B.A., M.H.A. | CEO of Care Delivery & Member of Management Board |
| Mr. Glenn Slater | Senior Vice President of Manufacturing and Supply Chain Operations |
| Mr. Joachim Weith | Senior Vice President of Corporate Communications & Governmental Affairs |
| Mr. Joseph E. Turk Jr. | CEO of Care Enablement & Member of Management Board |
| Mr. Martin Fischer | CFO & Member of the Management Board |
| Ms. Helen Giza | Chair of Management Board & CEO |
| Date | Type | Document |
|---|---|---|
| 2026-05-05 | 6-K | tm2613503d1_6k.htm |
| 2026-04-14 | 6-K | tm2611689d1_6k.htm |
| 2026-02-24 | IRANNOTICE | tm261139d2_irannotice.htm |
| 2026-02-24 | 6-K | tm261139d5_6k.htm |
| 2026-01-12 | 6-K | tm262757d1_6k.htm |
| 2025-12-10 | 6-K | tm2533187d1_6k.htm |
| 2025-11-17 | 6-K | tm2531468d1_6k.htm |
| 2025-11-04 | 6-K | tm2528516d2_6k.htm |
| 2025-10-01 | 6-K | tm2527732d1_6k.htm |
| 2025-09-19 | 6-K | tm2526545d1_6k.htm |